Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07342530 · ClinicalTrials.gov registry record · NA
Early Intervention for Postpartum PTSD: Comparing Written Exposure and Capnometry-Guided Breathing Therapy
A NA study, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT07342530: Recruiting NA study, sponsored by Stanford University.
NCT07342530 is a NA study that is actively recruiting participants, run by Stanford University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07342530, a NA study, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to examine two early interventions, Written Exposure Therapy and Capnometry Guided Breathing, to reduce post-traumatic stress disorder (PTSD) symptoms in women after childbirth as compared to usual care.
Primary Outcome
Proportion of participants who begin their assigned intervention (≥1 session for WET; completion of initial training for CGRI)
Interventions
- BEHAVIORAL Written Exposure Therapy (WET)
- DEVICE Capnometry-Guided Breathing Intervention (CGRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-03-09 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT07342530 shows while recruiting
NCT07342530 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Written Exposure Therapy (WET) is the first listed.
NCT07342530 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07342530 about?
NCT07342530 is a clinical study titled "Early Intervention for Postpartum PTSD: Comparing Written Exposure and Capnometry-Guided Breathing Therapy". The purpose of this study is to examine two early interventions, Written Exposure Therapy and Capnometry Guided Breathing, to reduce post-traumatic stress disorder (PTSD) symptoms in women after childbirth as compared to usual care.
What is the current status of trial NCT07342530?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-03-09. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07342530?
The interventions under investigation include: Written Exposure Therapy (WET) (BEHAVIORAL), Capnometry-Guided Breathing Intervention (CGRI) (DEVICE).
Who is sponsoring clinical trial NCT07342530?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07342530's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI